1.

[Report] Advisory Council on the Misuse of Drugs. (2026) ACMD report – A review of the evidence on the use and harms of etomidate and related compounds. London: Advisory Council on the Misuse of Drugs.

2.

[Article] Chen, Shuoqi and Aldabergenov, Daniyar and Alotaibi, Khalid S and Holland, Adam and Moore, Robert and Woodhouse, Rebecca and Hudson, Simon and Milton, Holly and Menzies, Eleanor and Parks, Claire and Lawson, Alexander J and Harris, Magdalena and Singer, Mervyn and Dyson, Alex and Copeland, Caroline S (2026) Is nitazene-related mortality underestimated? Findings from an in vivo and ex vivo rat study and pharmacoepidemiological analysis of coroner-reported deaths. Clinical Toxicology, Early online. https://doi.org/10.1080/15563650.2025.2601141

3.

[Article] McDonald, André J and Doggett, Amanda and Bondy, Susan J and Colman, Ian and Cook, Steven and Hamilton, Hayley A and Kurdyak, Paul and Leatherdale, Scott T and Myran, Daniel T and Rehm, Jürgen and Wickens, Christine M and MacKillop, James and Halladay, Jillian (2026) Adolescent cannabis use and psychological distress from 2013 to 2023: a population-based study in Ontario, Canada. Addiction, Early online. https://doi.org/10.1111/add.70333

4.

[Article] Ledlie, Shaleesa and Garg, Ria and Leece, Pamela and Kolla, Gillian and Hyshka, Elaine and Tadrous, Mina and Gomes, Tara (2026) Trends in fentanyl-containing drug samples seized by law enforcement agencies across Canada. Addiction, Early online. https://doi.org/10.1111/add.70314

5.

[Article] Burton, Sam and Cummings, Shannon and Connides-Smith, Charlotte and Fairweather, Elizabeth and Montgomery, Catharine and Rose, Abigail K and Whalley, Poppy and Jones, Andrew (2026) The stigma of alcohol use during pregnancy: exploring the impact of alcohol strength and social context on public perceptions. PLoS ONE, 21, (1). https://doi.org/10.1371/journal.pone.0339954

6.

[Article] Canadian Centre on Substance Use and Addiction, Canada’s Drug Agency. (2026) Drug-checking technologies to detect compositions of unregulated substance samples. Canadian Journal of Health Technologies, 6, (1). https://doi.org/10.51731/cjht.2026.1328

7.

[Report] Public Health Scotland. (2026) Rapid Action Drug Alerts and Response (RADAR) quarterly reports 2026. Edinburgh: Public Health Scotland.

8.

[Article] Nielsen, Suzanne and Silva, João Pedro and Jones, Jermaine D and Krotulski, Alex and Poovendran, Dilkushi and Muzangizi, Deusdedit and Forte, Gilles and White, Jason and Comer, Sandra D (2026) Behavioural effects and naloxone effectiveness with new synthetic opioids. Drug and Alcohol Review, 45, (1). https://doi.org/10.1111/dar.70040

9.

[Article] Roberts, Emmert and McKetin, Rebecca and Copeland, Caroline (2026) Characteristics of methamphetamine-related deaths in the United Kingdom, 1997-2024. Addiction, 121, (3), pp. 680-685. https://doi.org/10.1111/add.70215

10.

[Article] Stam, Nathan C and Shrestha, Monika and Tas, Basak and Furler, John and Bonomo, Yvonne and Strang, John (2026) Analysis of rapid onset heroin overdose cases from a supervised injecting facility in Melbourne, Australia. Addiction, 121, (2), pp. 296-304. https://doi.org/10.1111/add.70199

11.

[Report] Forensic Science Ireland. (2025) Forensic Science Ireland annual report 2024. Dublin: Forensic Science Ireland.

12.

[Report] Medical Bureau of Road Safety. (2025) Medical Bureau of Road Safety annual report 2024. Dublin: Medical Bureau of Road Safety.

13.

[Article] Shi, Qiongyu and Li, Guohua (2025) Cannabis use and suicide: a case-control study based on integrative data analysis. Journal of Cannabis Research, 7, (1). https://doi.org/10.1186/s42238-025-00352-1

14.

[Report] Advisory Council on the Misuse of Drugs. (2025) A review of the evidence on the use and harms of Carisoprodol. London: Advisory Council on the Misuse of Drugs.

15.

[Report] Public Health Scotland. (2025) Rapid Action Drug Alerts and Response (RADAR) quarterly reports 2025. Edinburgh: Public Health Scotland.

16.

[Article] Hunter, William Ross and Rapp-Wright, Helena and Francis, William and White, Margarita and Richardson, Alexandra K and Christy, Cryshanthi and Shiels, Faye and Mellon-Kane, Ciara and O'Kane, Eugene and McElarney, Yvonne and Moore, Heather and Barron, Leon P (2025) An environmental risk assessment of contamination of lakes and rivers in Northern Ireland with pharmaceuticals, personal care products and drugs of abuse. Environmental Science. Processes & impacts, 27, (10), pp. 3163-3179. https://doi.org/10.1039/d5em00435g

17.

[Report] Healthcare Pricing Office, Health Service Executive. (2025) Activity of acute public hospitals in Ireland 2024 annual report. Dublin: Health Service Executive.

18.

[Article] Durand, Louise and O'Kane, Aoife and Maguire, Richard and Ryan, Aisling and Cusack, Denis and Keenan, Eamon and Cousins, Gráinne (2025) Drug and polydrug detection in drivers suspected of driving under the influence of an intoxicant in Ireland 2012-2018: a national repeated cross-sectional study. Traffic Injury Prevention, Early online. pp. 1-9. https://doi.org/10.1080/15389588.2025.2544346

19.

[Report] WHO Expert Committee on Drug Dependence. (2025) Coca leaf - Critical review report [draft]. London: International Drug Policy Consortium.

20.

[Report] Wilson, Luke B and McGrane, Ellen and Angus, Colin and Kersbergen, Inge and Pryce, Robert and Stevely, Abigail and Holmes, John (2025) Alcohol-free and low-alcohol drinks in Great Britain: monitoring report on 2023 data. Sheffield: University of Sheffield.

21.

[Article] Spinazzola, Edoardo and Degen, Hannah and Austin-Zimmerman, Isabelle and Trotta, Giulia and Chesney, Edward and Li, Zhikun and Alameda, Luis and Leung, Bok Man and Lang, Yifei and Quattrone, Andrea and Quattrone, Diego and Castrignanò, Erika and Wolff, Kim and Murray, Robin and Freeman, Tom P and Di Forti, Marta (2025) Are reasons for first using cannabis associated with subsequent cannabis consumption (standard THC units) and psychopathology? BMJ Mental Health, 28. https://doi.org/10.1136/bmjment-2025-301810

22.

[Article] Li, Sophie and Solmi, Marco and Myran, Daniel T and Fabiano, Nicholas (2025) Cannabis and psychosis. Canadian Medical Association Journal, 197, (27). DOI: https://doi.org/10.1503/cmaj.250659

23.

[Article] Marland, Victoria and Nisbet, Lorna and Nic Daéid, Niamh (2025) Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples. Harm Reduction Journal, 22. https://doi.org/10.1186/s12954-025-01287-9

24.

[Video] Darke, Shane (2025) NDARC webinar series presentation. Clinical characteristics of heroin overdose deaths among older adults in Australia, 2000-2025. National Drug and Alcohol Research Centre, UNSW Sydney.

25.

[Article] Piatkowski, Timothy and Kill, Emma and Reeve, Steph (2025) ‘The gear could be cut with fentanyl which is starting to happen more in Australia’: exploring overdose survivors’ perspectives on toxic supply and safe consumption. Drugs: Education Prevention and Policy, 32, (1), pp. 42-50. https://doi.org/10.1080/09687637.2024.2392520

26.

[Webpage] Health Service Executive. (2025) Spiking. URL: https://www2.hse.ie/conditions/spiking/

27.

[Webpage] Center for Forensic Science Research and Education. (2025) CSFRE new psychoactive substances (NPS). Scope recommendations. URL: https://www.cfsre.org/nps-discovery/scope-recommen...

28.

[Report] United Nations Office on Drugs and Crime, World Health Organization. (2025) Contaminated medicines and integrity of the pharmaceutical excipients supply chain. Vienna: UNODC and WHO.

29.

[Report] European Union Drugs Agency. (2025) Drug supply, production and precursors – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

30.

[Report] European Union Drugs Agency. (2025) EUDA initial report on the new psychoactive substance 2-methylmethcathinone (2-MMC). Lisbon: EUDA.

31.

[Report] European Union Drugs Agency. (2025) EUDA initial report on the new psychoactive substance 4-bromomethcathinone (4-BMC). Lisbon: EUDA.

32.

[Report] European Union Drugs Agency. (2025) EUDA initial report on the new psychoactive substance N-ethylnorpentedrone (NEP). Lisbon: EUDA.

33.

[Dataset] European Union Drugs Agency. (2025) EUDA statistical bulletin - data and statistics on the drug situation in Europe.

34.

[Report] European Union Drugs Agency. (2025) MDMA – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

35.

[Report] European Union Drugs Agency. (2025) Understanding Europe’s drug situation in 2024 – key developments (European Drug Report 2025). Lisbon: EUDA.

36.

[Article] Stangeland, Marcus and Dale, Ola and Skulberg, Arne Kristian (2025) Nitazenes: review of comparative pharmacology and antagonist action. Clinical Toxicology, 63, (6), pp. 393-406. https://doi.org/10.1080/15563650.2025.2504133

37.

[Article] HSE drugs.ie. (2025) HSE Ketamine update 2025. drugs.ie,

38.

[Article] HSE drugs.ie. (2025) HSE MDMA update May 2025. drugs.ie,

39.

[Article] Nham, Amy and Le, John N and Thomas, Shawn A and Gressick, Kimberly and Ussery, Emily N and Ko, Jean Y and Gladden, R Matt and Mikosz, Christina A and Schier, Joshua G and Vivolo-Kantor, Alana and Fiorillo, Maria and McMaster, McKenna and Magana, Darlene Nolasco and Verklan-McInnes, Livia and Wahl, Michael and Wood, Taylor and Adams, Axel and Krotulski, Alex and Trecki, Jordan and Ellison, Ross and Gerona, Roy and Arunkumar, Ponni and Mir, Mojde and Wise, Leslie M and Betancourt, Emma and Monty, Kathleen and Gulmatico, Jhoanna and Pojas, Angie and Fitzgerald, Ruchi and Hua, Miao (2025) Overdoses involving medetomidine mixed with opioids - Chicago, Illinois, May 2024. MMWR. Morbidity and mortality weekly report, 74, (15), pp. 258-265. /10.15585/mmwr.mm7415a1

40.

[Report] Advisory Council on the Misuse of Drugs. (2025) ‘Semi-synthetic’ cannabinoids: cannabinoids related to tetrahydro- cannabinol and cannabidiol. London: Advisory Council on the Misuse of Drugs.